Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease
Abstract As previous studies have reported finding an association between hyperuricemia and the development of cardiovascular and chronic kidney disease, hyperuricemia is thought to be an independent risk factor for hypertension and diabetic mellitus. However, we have not been able to determine whet...
Guardado en:
Autores principales: | Hirotaka Saito, Kenichi Tanaka, Tsuyoshi Iwasaki, Akira Oda, Shuhei Watanabe, Makoto Kanno, Hiroshi Kimura, Michio Shimabukuro, Koichi Asahi, Tsuyoshi Watanabe, Junichiro James Kazama |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05a79b92278a486b9d5ae6e777f6cab9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted knock-in mice expressing the oxidase-fixed form of xanthine oxidoreductase favor tumor growth
por: Teruo Kusano, et al.
Publicado: (2019) -
Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice
por: Maimaiti Yisireyili, et al.
Publicado: (2017) -
High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes
por: Haruka Saito, et al.
Publicado: (2021) -
Xanthine Oxidase Inhibitor Allopurinol Prevents Oxidative Stress‐Mediated Atrial Remodeling in Alloxan‐Induced Diabetes Mellitus Rabbits
por: Yajuan Yang, et al.
Publicado: (2018) -
Xanthine oxidoreductase: A leading actor in cardiovascular disease drama
por: Letizia Polito, et al.
Publicado: (2021)